Immuron Ltd has released a press release.
Immuron launch PROIBS for IBS
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Immuron
- Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.
- Immuron Q1 FY26 YoY growth
- Immuron Submits IMM-529 IND to FDA
- Immuron Letter to Shareholders – Projects Update
- FY25 Results Presentation
Later from Immuron
- Clinical Trial Update
- Immuron Announces Clinical Trial Update
- IMM-529 IND approved by FDA
- Immuron New U.S. Department of Defense Award & Clinical Trial Update
- Uniformed Services University to Release Topline Data
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron